Achillion’s CEO Milind Deshpande steps down; NeuroVision raises $11.2M for novel Alzheimer’s detection tech
→ Milind Deshpande is stepping down from Achillion $ACHN, the biotech he’s led for the better part of the last two decades, first as CSO and then as CEO. His departure leaves the faded hep C star in the hands of former COO Joseph Truitt, who already has the president
Name: Milind Deshpande
Continent: North America
Country: USA
Company: Achillion Pharmaceuticals
Branch: Pharma
Position: CEO
Reason: Resigned
Announcement Date: May 01, 2018, 10:00pm
Resignation Date: May 01, 2018, 10:00pm